Latest Merrill Lynch Stories

ALMELO, Netherlands, May 22, 2013 /PRNewswire/ -- Sensata Technologies Holding N.V. (NYSE: ST) today announced that certain of its existing shareholders have agreed to sell 12,500,000 ordinary shares in an underwritten public offering. Sensata Technologies will not receive any proceeds from this offering. The offering is expected to close on May 28, 2013. BofA Merrill Lynch and Morgan Stanley & Co. LLC acted as joint book-running managers of the offering. The underwriters may...

PLEASANTON, Calif., May 14, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Bank of America Merrill Lynch 2013 Health Care Conference on Thursday, May 16. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 10:40 a.m., Pacific Daylight Time (1:40 p.m.,...

CALGARY, May 14, 2013 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Bank of America Merrill Lynch Health Care Conference on Thursday, May 16(th), 2013 at 10:40 a.m. PT. The conference will take place from May 14(th) to May 16(th) at Encore at Wynn Las Vegas in  Las Vegas, NV. A live audio link to the webcast presentation is available at:...

PRINCETON, N.J., May 13, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013 at 11:00 a.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early. Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most...

PARSIPPANY, N.J., May 13, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a global specialty pharmaceutical leader, today confirmed that Actavis has cancelled its appearance at the upcoming Bank of America Merrill Lynch Healthcare Conference. Actavis had been scheduled to present on Tuesday, May 14, 2013 at 8:40 AM Pacific Time at the Encore at the Wynn in Las Vegas, Nevada. About Actavis, Inc. Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company...

HOUSTON, May 10, 2013 /PRNewswire/ -- EV Energy Partners, L.P. (NASDAQ: EVEP) today announced that Mr. Michael Mercer, Senior Vice President and CFO, will be presenting at the Bank of America Merrill Lynch 2013 Global Energy and Power Leveraged Finance Conference in New York on Monday, May 13, 2013 at 3:20 p.m. Eastern Time. The live webcast and presentation slides will be available on EV Energy Partners' website at www.evenergypartners.com under "Investor Relations - Presentations...

CALGARY, May 9, 2013 /PRNewswire/ - WestJet's President and CEO Gregg Saretsky will be presenting at the Bank of America Merrill Lynch 2013 Global Transportation Conference on Thursday, May 16, 2013. Date: Thursday, May 16, 2013 Time: 5:40 a.m. PST / 6:40 a.m. MST / 8:40 a.m. EST Location: Boston, MA The Bank of America Merrill Lynch 2013 Global Transportation Conference will be webcast. Financial analysts, media and other interested...

MONTREAL, May 8, 2013 /PRNewswire/ - Jim Vena, executive vice-president and chief operating officer of CN (TSX: CNR) (NYSE: CNI), will address the Bank of America Merrill Lynch Global Transportation Conference on May 16 in Boston, Mass., at 11.20 a.m. Eastern Daylight Time. Vena will discuss how CN's focus on customer engagement and operational and service excellence is helping the company's customers compete better in their end markets while delivering solid CN operating...

NATICK, Mass., May 8, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2013 Healthcare Conference on May 15 in Las Vegas. Jeff Capello, executive vice president and chief financial officer, will participate in a 30-minute question and answer session regarding the company beginning at approximately 8:40 a.m. PT. A live webcast of the question and answer session will be available to interested parties via...

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Bank of America Merrill Lynch Health Care Conference at the Encore at the Wynn Hotel in Las Vegas, NV on May 14-16, 2013. Paul V. Maier, Chief Financial Officer, will present on Thursday, May 16, 2013 beginning at 12:00 p.m. PDT, to provide an overview of and update on...